Key facts
- Rhazes AI’s last known valuation is $5.0M (Feb 2025).
- It has raised $680K.
- Notable investors include Plug and Play Tech Center, AWS Startups, Hatcher+, Qatar Development Bank, Minnow Venture Partners — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Rhazes AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Rhazes AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Rhazes AI
Developer of an AI-powered solution for a clinician productivity platform intended to streamline clinicians' workflows and reduce administrative burdens. The company's platform offers a comprehensive assistant that enhances diagnostic accuracy, transcription, and specialist-level support and documentation efficiency, enabling healthcare professionals to save time, reduce burnout, and provides an intelligent scribe that can handle all their paperwork and admin tasks so they can focus on patients.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2023
- Employees
- 6
- Website
- rhazes.ai/
- Ownership
- Privately Held (backing)
Rhazes AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rhazes AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rhazes AI in its N-PORT filings yet. We sweep new filings monthly.